Column Mid Cap holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Column Mid Cap Fund CFMCX
- NAV / 1-Day Return $13.60 / −1.18 %
- Fund Size $1.1B
- Adjusted Expense Ratio 0.490%
- Net Expense Ratio 0.490%
- Fee Level: Distribution Low
- Share Class Type No Load
- Morningstar Category Mid-Cap Blend
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.79%
- Turnover Ratio 49%
Morningstar’s Analysis CFMCX
Will CFMCX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 11.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs X | 2.66 | 29M | Cash and Equivalents |
AMETEK Inc | 1.55 | 17M | Industrials |
Ross Stores Inc | 1.54 | 17M | Consumer Cyclical |
Westinghouse Air Brake Technologies Corp | 1.28 | 14M | Industrials |
Monolithic Power Systems Inc | 1.21 | 13M | Technology |
West Pharmaceutical Services Inc | 1.05 | 11M | Healthcare |
Keysight Technologies Inc | 1.04 | 11M | Technology |
IQVIA Holdings Inc | 1.04 | 11M | Healthcare |
Twilio Inc Class A | 0.94 | 10M | Technology |
Labcorp Holdings Inc | 0.93 | 10M | Healthcare |